Clinical Trials on Stroke Nos Without Residual Deficits

Total 400 results

Federal University of Health Science of Porto Alegre

Completed

The Use of Brace to Retrain Hemiparetic Gait

Stroke Nos Without Residual Deficits
The London Spine Centre

Completed

Brace Versus No Brace for the Treatment of Thoracolumbar Burst Fractures Without Neurologic Injury

Thoracolumbar Burst Fractures Without Neurologic Deficit

Canada
Xianmin Song, MD

Recruiting

Next Generation Sequencing（NGS）Monitors Minimal Residual Disease（MRD）in Allo-PBSCT Patients

NGS Monitor MRD

China
Fondation Lenval

Completed

Emotional Information Processing in Attention Deficit Disorder With or Without Hyperactivity (TIVE-TDA)

Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without Hyperactivity

France
VA Office of Research and Development

Recruiting

An Engineering-Based Balance Assessment and Training Platform (BATP)

Stroke | Balance Deficits

United States
Stony Brook University
National Center for Neuromodulation for Rehabilitation

Terminated

Transcranial Direct Current Stimulation (tDCS) in Post-Stroke Working Memory Deficits (TDCS-PSMWD)

Stroke | Cognitive Impairment | Cognitive Deficit | Short-Term Memory Impairment

United States
Ain Shams University

Unknown

National Egyptian Network Pediatric Stroke and Hemiplegia Registry

Stroke With Hemiparesis | Perinatal Stroke | Focal Neurologic Deficits

Egypt
University of Zurich
ETH Zurich, Human Nutrition Laboratory

Completed

The Influence of Different Food Componente on Zinc Absorption in Young Adults Consuming Zinc Fortified Porridges Prepared From Maize, Beans and Sorghum: a Series of Six Similar Randomized, Single-blind Studies

Study Not Related to a Disease. Nutrition Study Without Drug Administration.

Switzerland
Bradley Hospital
National Institute of Mental Health (NIMH)

Unknown

Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls (BBPP)

Healthy | Generalized Anxiety Disorder | Bipolar Disorder | Attention Deficit Disorder With Hyperactivity | Attention Deficit Disorder Without Hyperactivity

United States
Loma Linda University

Withdrawn

Gaming Apps Post-Stroke (GAPS)

Stroke | Cognitive Impairment | Cognitive Change | Executive Dysfunction | Cognitive Deficit

United States
Hospices Civils de Lyon

Not yet recruiting

Stimulate One Hand to Improve Tactile Perception on the Other (HAND-HAND)

Post-stroke Sensory Deficits at the Hand

France
Hippocration General Hospital
Win Medica; Pharmassist Ltd

Recruiting

Flecainide Versus Amiodarone in the Cardioversion of Paroxysmal Atrial Fibrillation at the Emergency Department, in Patients With Coronary Artery Disease Without Residual Ischemia (FLECA-ED)

Atrial Fibrillation Paroxysmal | Coronary Artery Disease Without Residual Ischemia

Greece
Centre Henri Becquerel
U918 ( Inserm unit)

Completed

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS (LymphoSeq)

Non Hodgkin Lymphoma

France
Guangdong Provincial People's Hospital

Completed

Pathological Tumor and Lymph Node Responses After Neoadjuvant Immunochemotherapy in Initially-unresectable NSCLC

Chemotherapy | Non Small Cell Lung Cancer | Immunotherapy | Tumour, Residual

China
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center; Mayo Clinic; University of Pennsylvania; University...

Active, not recruiting

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

Aggressive | B-cell Non-Hodgkin Lymphoma

United States
Hunan Province Tumor Hospital

Completed

Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment

Non Small Cell Lung Cancer

China
University Hospital, Grenoble
Commissariat A L'energie Atomique; Équipe 5 Neuroimagerie et perfusion cérébrale...

Recruiting

Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS) (TINNOP3-DBS)

Severe Permanent Uni or Bilateral Non-pulsatile Tinnitus | Without Associated Vestibular Pathology | Resistant to Therapeutic Failure | With or Without Hearing Loss

France
Meir Medical Center
Assuta Ashdod Hospital; Rabin Medical Center; Tel-Aviv Sourasky Medical Center; Ziv Medical Center

Recruiting

Adjustment of Chemotherapy Duration in Follicular Lymphoma According to Minimal Residual Disease Status (FLMRD)

Follicular Lymphoma

Israel
Shanghai Chest Hospital

Recruiting

Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation

Non-small Cell Lung Cancer | Minimal Residual Disease | Immunotherapy | Anti-angiogenesis

China
Swiss SOS Study Group
Universitätsklinik für Neurochirurgie, Inselspital Bern; Département des Neurosciences... and other collaborators

Terminated

Swiss SOS MoCA - DCI Study

Stroke | Cognitive Impairment | Subarachnoid Hemorrhage | Delayed Cerebral Ischemia | Complication | Cognitive Deficit | Cognitive Deterioration | Cognitive Deficits Following Cerebral Infarction

Switzerland
Histograft Co., Ltd.
S. M. Kirov Military Medical Academy of the Ministry of Defense of the Russian...

Unknown

Comparative Study of Gene-activated Bone Substitute and Autobone in Treatment of Long Bone Nonunions

Non Union Fracture | Non-Union of Ankle Joint Without Infection

Russian Federation
Josep Rodes-Cabau

Active, not recruiting

Medical Treatment With or Without Transcatheter Patent Foramen Ovale Closure (STOP)

Patent Foramen Ovale | Cryptogenic Stroke | Older Patients | Medical Treatment | Recurrent Stroke

Canada
Nobles Medical Technologies II Inc

Suspended

NobleStitch EL STITCH Trial is a PFO Comparative Trial (STITCH)

Foramen Ovale, Patent | Stroke, Ischemic

United States, Italy
Lifetech Scientific (Shenzhen) Co., Ltd.

Withdrawn

Safety and Efficacy of IrisFIT™ Patent Foramen Ovale Occluders

Patent Foramen Ovale | Cryptogenic Stroke

China
Bristol-Myers Squibb

Withdrawn

An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease (CheckMate 9TN)

Non-Small Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Circulating Tumor DNA
Lifetech Scientific (Shenzhen) Co., Ltd.

Recruiting

Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.

Patent Foramen Ovale | Cryptogenic Stroke

China
University Health Network, Toronto
Inivata; The Princess Margaret Cancer Foundation; Ontario Institute for Cancer...

Recruiting

Using ctDNA to Detect Minimal Residual Disease After Lung Cancer Resection

Non Small Cell Lung Cancer

Canada
Encore Medical Inc.
Bright Research Partners; Yale Cardiovascular Research Group

Recruiting

Encore PFO Closure Device - The PerFOrm Trial

Patent Foramen Ovale | Cryptogenic Stroke

United States
Alliance Equiphoria
Boehringer Ingelheim; Centre Hospitalier Sud Francilien

Recruiting

Neurorehabilitation Through Hippotherapy of a Brain Stroke (HippoPostCVA)

Quality of Life | Cerebrovascular Accident | Cognitive Deficit | Neuroplasticity | Psychological Trauma | Caregiver Burnout | Neurorehabilitation | Hippotherapy | Silent Neurofunctional Barriers | Functional Deficit | Autonomy

France
Qingdao Central Hospital
Yake Biotechnology Ltd.

Unknown

CD19-targeted CAR-T Cell Therapy for MRD+ B-cell Malignancies After Autologous Stem Cell Transplantation

Lymphoma, B-Cell | Leukemia, B-Cell | Minimal Disease, Residual

China
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission

Mantle Cell Lymphoma | CD20 Positive

United States
Gachon University Gil Medical Center

Completed

Residual Shunt After Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke

Patent Foramen Ovale | Closure; Foramen Ovale

Korea, Republic of
Memorial Sloan Kettering Cancer Center

Recruiting

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Minimal Residual Disease | NSCLC Stage IV | Nsclc | Metastatic Non Small Cell Lung Cancer

United States
Yocheved Laufer
Clalit Health Services, Haifa and West Galilee

Completed

The Effects of Lower Extremity Sensory Retraining Treatment in Individuals With Post-stroke Sensory Impairment

Stroke | Sensory Deficits

Israel
MC Medicor
University of Ljubljana, Faculty of Medicine

Recruiting

Long-term Outcomes After Percutaneous Closure of PFO

Atrial Fibrillation | Foramen Ovale, Patent | Echocardiography | Embolic Stroke

Slovenia
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France; W.L.Gore & Associates; Abbott; Centre Hospitalier St... and other collaborators

Not yet recruiting

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years (CLOSE-2)

Patent Foramen Ovale | Cryptogenic Ischemic Stroke

France
Raban Jeger

Recruiting

Atrial Fibrillation Before and After Patent Foramen Ovale Closure Study (ALFA ROMEO)

Atrial Fibrillation | Foramen Ovale, Patent | Cryptogenic Stroke

Switzerland
Jae-Kwan Song

Unknown

Device Closure Versus Medical Therapy for Cryptogenic Stroke Patients With High-Risk Patent Foramen Ovale (DEFENSE-PFO)

Patent Foramen Ovale

Korea, Republic of
Massachusetts General Hospital
Eli Lilly and Company

Completed

Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)

ADHD NOS

United States
MicroTransponder Inc.

Completed

VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke

Stroke | Upper Limb Deficits

United States
University Hospital, Saarland

Recruiting

PFO Occlusion and Atrial Fibrillation

Patent Foramen Ovale | Atrial Fibrillation New Onset | Embolic Stroke of Undetermined Source

Germany
W.L.Gore & Associates

Recruiting

Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder (GSO-PFO PMS)

Stroke | TIA | Cryptogenic Stroke | PFO - Patent Foramen Ovale

Japan
Cierra

Completed

The Paradigm II Trial: PFX Closure System in Subjects With Cryptogenic Stroke, Transient Ischemic Attack, Migraine or Decompression Illness

Foramen Ovale, Patent

Germany
NovaSignal Corp.

Completed

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt (BUBL)

Transient Ischemic Attack | Patent Foramen Ovale | Embolic Stroke of Undetermined Source | Right-To-Left Atrial Shunt

United States
Centre Hospitalier Universitaire de Besancon

Active, not recruiting

Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study (PFO-AF)

Stroke | Atrial Fibrillation | Patent Foramen Ovale

France
KU Leuven

Completed

Validity and Reliability of a Self-evaluation Tool for Cognitive Deficits in the Acute Stage After Stroke

Cognitive Dysfunction | Stroke, Acute

Belgium
Asan Medical Center
Medtronic

Recruiting

Evaluation of Prevalence and Clinical Impact of Atrial Fibrillation in Elderly Patients With Cryptogenic Stroke and High-Risk Patent Foramen Ovale (DefenseElderly)

Cryptogenic Stroke | High Risk Patent Foramen Ovale

Korea, Republic of
Assistance Publique - Hôpitaux de Paris
Fonds de Dotation ACTION

Active, not recruiting

Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia (AFLOAT)

Patent Foramen Ovale | Cryptogenic Stroke | Atrial Arrhythmia

France
Occlutech International AB

Active, not recruiting

The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO (PROOF)

Stroke | PFO - Patent Foramen Ovale

France, Germany, Italy, Canada
Second Affiliated Hospital, School of Medicine,...

Not yet recruiting

Multicenter Registry for Assessment of Markers of Early Neurological Deterioration in Primary Intracerebral Hemorrhage (CATCH)

Hemorrhage | Hemorrhagic Stroke | Intracerebral Hemorrhage | Neurologic Deficits

China

Clinical Trials on Stroke Nos Without Residual Deficits

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations